---
title: Enzene Biosciences vs JSR Life Sciences
slug_a: enzene
slug_b: jsrlifesciences
site: cdmo
review_signal_gate: closed
canonical_path: /compare/enzene/jsrlifesciences
---

# Enzene Biosciences vs JSR Life Sciences

Side-by-side profile data from each company listing on this directory.

## Enzene Biosciences

- Profile: [/companies/enzene](/companies/enzene)

Enzene Biosciences — Global CDMO specializing in cost-effective biologics and biosimilars manufacturing using patented continuous bioprocess technology (EnzeneX®). Offers integrated drug discovery, development, and manufacturing services with facilities in India and expanding presence in the USA and Europe.

Services: 10. Modalities: 3. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian

## JSR Life Sciences

- Profile: [/companies/jsrlifesciences](/companies/jsrlifesciences)

JSR Life Sciences — CDMO and CRO offering downstream processing, protein purification, and manufacturing capabilities for therapeutic antibodies and biologics from discovery through commercialization.

Services: 4. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (4).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Downstream Processing

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian